As of 2025-09-18, the Intrinsic Value of Design Therapeutics Inc (DSGN) is -5.57 USD. This DSGN valuation is based on the model Peter Lynch Fair Value. With the current market price of 5.95 USD, the upside of Design Therapeutics Inc is -193.68%.
Based on its market price of 5.95 USD and our intrinsic valuation, Design Therapeutics Inc (DSGN) is overvalued by 193.68%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -5.57 - -5.57 | -5.57 | -193.68% |
| P/E | (15.50) - (15.05) | (15.02) | -352.5% |
| DDM - Stable | (10.19) - (37.69) | (23.94) | -502.4% |
| DDM - Multi | (7.41) - (21.68) | (11.09) | -286.4% |
| Market Cap (mil) | 338.85 |
| Beta | 1.38 |
| Outstanding shares (mil) | 56.95 |
| Enterprise Value (mil) | 319.15 |
| Market risk premium | 4.60% |
| Cost of Equity | 9.16% |
| Cost of Debt | 5.00% |
| WACC | 6.52% |